Vtv Therapeutics Inc. [VTVT]

Source: 

Company Overview

Vtv Therapeutics Inc is a clinical stage pharmaceutical company focused on treating metabolic and inflammatory diseases to minimize their long- term complications and improve the lives of patients. We have an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates. Our lead program is TTP399, an orally administered, small molecule, liver-selective glucokinase activator as an adjunctive therapy to insulin for the treatment of type 1 diabetes.